Drug:
Reaction: BLOOD GLUCOSE INCREASED
20250101 - 20251231
No. 801 - 900
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 801 | 24985040 |
US |
1 | |
Blood glucose increased, Accidental underdose, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN ASPART, |
||||
| 802 | 24985608 |
EG |
76 | 2 |
Pneumonitis, Fatigue, Blood glucose increased, Blood cholesterol increased, Vaginal infection, Ulcer, Tumour marker increased, Off label use, Pyrexia, Lymphocyte count decreased, |
||||
EVEROLIMUS, EVEROLIMUS, RIBOCICLIB, RIBOCICLIB, |
||||
| 803 | 24986254 |
US |
1 | |
Platelet count increased, Blood glucose increased, |
||||
ADALIMUMAB, |
||||
| 804 | 24986471 |
US |
58 | 2 |
Blood glucose increased, COVID-19, Photopsia, Migraine, Muscular weakness, Vomiting, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 805 | 24986682 |
CO |
62 | 1 |
Platelet count decreased, Blood glucose increased, Arthritis infective, |
||||
SECUKINUMAB, |
||||
| 806 | 24986917 |
US |
53 | 1 |
Blood glucose increased, Product storage error, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 807 | 24986967 |
US |
72 | 1 |
Blood glucose increased, Incorrect dose administered, Visual impairment, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 808 | 24987014 |
CA |
||
Blood glucose increased, Nausea, Vomiting, Incorrect dose administered, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 809 | 24987024 |
EG |
13 | 1 |
Diabetic ketoacidotic hyperglycaemic coma, Hypertension, Hypertension, Abscess, Injection site abscess, Injection site fibrosis, Blood glucose increased, Nasopharyngitis, Dizziness, Vomiting, Abdominal pain, Wrong technique in product usage process, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 810 | 24987461 |
RS |
60 | 1 |
Cardiac failure acute, Atrial fibrillation, Hepatomegaly, Cardiomyopathy, Drug resistance, Pleural effusion, Blood glucose increased, Blood cholesterol increased, Hyperlipidaemia, Hyperglycaemia, Hypercholesterolaemia, Cytogenetic response, |
||||
NILOTINIB, |
||||
| 811 | 24987628 |
CN |
||
Syncope, Blood glucose increased, |
||||
| 812 | 24987681 |
US |
||
Pigmentation disorder, Muscle atrophy, Glycosylated haemoglobin increased, Libido decreased, Blood glucose increased, Hot flush, Blood triglycerides increased, |
||||
RELUGOLIX, RELUGOLIX, ERGOCALCIFEROL, ABIRATERONE ACETATE, ABIRATERONE, PREDNISONE, GLUTAMINE, |
||||
| 813 | 24987694 |
US |
||
Sacral pain, Nipple pain, Frustration tolerance decreased, Arthralgia, Bone pain, Blood glucose increased, Musculoskeletal pain, Fatigue, Hot flush, |
||||
RELUGOLIX, RELUGOLIX, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, OIL, BIOTIN, HAIR, GALANTAMINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LOSARTAN, VITAMIN C, MAGNESIUM OXIDE, ENZALUTAMIDE, |
||||
| 814 | 24989979 |
31 | 2 | |
Tremor, Hyperhidrosis, Suicidal ideation, Panic attack, Dizziness, Asthenia, Blood glucose increased, Heart rate abnormal, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 815 | 24978594 |
US |
76 | 2 |
Syncope, Face injury, Arthralgia, Glycosylated haemoglobin increased, Blood glucose increased, Blood glucose increased, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 816 | 24978702 |
US |
65 | 2 |
Increased appetite, Drug ineffective, Blood glucose increased, Weight increased, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 817 | 24978733 |
CO |
85 | 1 |
Blindness unilateral, Blood glucose increased, Glaucoma, |
||||
RISANKIZUMAB-RZAA, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SEMAGLUTIDE, |
||||
| 818 | 24978919 |
CN |
70 | 1 |
Myelosuppression, Blood glucose increased, Gastrointestinal neoplasm, Sleep disorder, Pancreatic neoplasm, Nasopharyngitis, White blood cell count increased, |
||||
POLATUZUMAB VEDOTIN, RITUXIMAB, BENDAMUSTINE HCL, |
||||
| 819 | 24979065 |
US |
58 | 2 |
Autoimmune thyroiditis, Visual impairment, Diplopia, Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 820 | 24979355 |
CO |
2 | |
Seizure, Pyrexia, Blood glucose increased, |
||||
INSULIN DEGLUDEC AND LIRAGLUTIDE, |
||||
| 821 | 24979357 |
CO |
78 | 1 |
Suffocation feeling, Lung disorder, Blood glucose increased, |
||||
ORAL SEMAGLUTIDE, |
||||
| 822 | 24979395 |
CL |
74 | 1 |
Device mechanical issue, Device failure, Blood glucose increased, Nervousness, Hyperhidrosis, Muscle spasms, Loss of consciousness, Tremor, |
||||
| 823 | 24979411 |
US |
2 | |
Blood glucose increased, |
||||
EMPAGLIFLOZIN, |
||||
| 824 | 24979905 |
US |
36 | 2 |
Seizure, Blood glucose increased, Syncope, Drug hypersensitivity, |
||||
ONABOTULINUMTOXINA, PANCRELIPASE, |
||||
| 825 | 24979984 |
US |
16 | 1 |
Blood glucose increased, Inappropriate schedule of product administration, Product storage error, |
||||
INSULIN GLARGINE, |
||||
| 826 | 24980313 |
US |
70 | 2 |
Product dose omission issue, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 827 | 24980328 |
US |
73 | 1 |
Incorrect dose administered, Blood glucose increased, Cataract, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 828 | 24981610 |
SK |
20 | 1 |
Pyelocaliectasis, Renal impairment, Urinary retention, Sinus tachycardia, Lipids increased, Blood uric acid increased, Blood pressure increased, Urinary incontinence, Blood creatinine increased, Blood glucose increased, |
||||
CLOZAPINE, |
||||
| 829 | 24981727 |
66 | ||
Pyrexia, Acute kidney injury, Pyelonephritis, Blast cell count increased, Vomiting, Tremor, Thirst, Palpitations, Back pain, Procalcitonin increased, Alpha 1 globulin abnormal, Anion gap increased, Basophil count increased, Blood albumin decreased, Blood alkaline phosphatase increased, Blood bilirubin increased, Blood calcium decreased, Blood chloride decreased, Blood glucose increased, Blood potassium decreased, Blood pressure abnormal, Blood sodium decreased, Drug level decreased, Epstein-Barr virus test positive, Immunoglobulins abnormal, Monocyte count increased, Protein total decreased, Troponin T, Splenomegaly, Dyspnoea, Nausea, Aspartate aminotransferase increased, Weight decreased, |
||||
RUXOLITINIB, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, ALLOPURINOL, CYCLOBENZAPRINE, DICLOFENAC, DICLOFENAC SODIUM, NALOXONE, ROSUVASTATIN, |
||||
| 830 | 24981748 |
US |
48 | 2 |
Blood glucose increased, Product storage error, Wrong patient received product, Drug ineffective, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 831 | 24981757 |
US |
51 | 1 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, |
||||
| 832 | 24982050 |
US |
68 | 1 |
Blood glucose increased, Drug ineffective, Product dose omission issue, |
||||
SITAGLIPTIN, GLIPIZIDE, |
||||
| 833 | 24982181 |
ZA |
57 | 1 |
Laboratory test abnormal, Electrocardiogram abnormal, Blood 25-hydroxycholecalciferol decreased, Blood uric acid increased, Creatinine urine increased, Albumin urine present, Carbon dioxide decreased, Blood creatine phosphokinase MB increased, Glycosylated haemoglobin increased, Blood glucose increased, Serum ferritin increased, C-reactive protein increased, Troponin increased, |
||||
INCLISIRAN, |
||||
| 834 | 24982318 |
US |
66 | 2 |
Myocardial infarction, Breast haemorrhage, Vaginal haemorrhage, Eye colour change, Vision blurred, Hypoaesthesia, Migraine, Blood glucose increased, Drug ineffective, Blood glucose decreased, |
||||
INSULIN HUMAN, INSULIN HUMAN, |
||||
| 835 | 24982321 |
CA |
70 | 2 |
Vomiting, Blood glucose decreased, Blood glucose increased, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, LEVOTHYROXINE SODIUM, RAMIPRIL, |
||||
| 836 | 24982329 |
US |
1 | |
Influenza, Blood potassium abnormal, Blood magnesium abnormal, Renal disorder, Drug ineffective, Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN HUMAN, INSULIN GLARGINE, |
||||
| 837 | 24982330 |
US |
56 | 2 |
Pancreatic carcinoma, Blood glucose increased, Wrong technique in product usage process, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 838 | 24982616 |
DE |
42 | 1 |
Vomiting, Diarrhoea, Renal pain, Dizziness, Pallor, Asthenia, Syncope, Delirium, Fear of death, Cardiovascular disorder, Hyperkalaemia, Hyperhidrosis, Hypotension, Hypothermia, Blood glucose increased, Electrolyte imbalance, Hyperhidrosis, Paraesthesia, Sinus tachycardia, Electrocardiogram QT prolonged, Renal impairment, |
||||
TIRZEPATIDE, |
||||
| 839 | 24982659 |
US |
40 | 1 |
Blood glucose increased, Road traffic accident, Hypoglycaemia, Inappropriate schedule of product administration, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, LEVOTHYROXINE, PROPRANOLOL HYDROCHLORIDE, DICLOFENAC, DICLOFENAC SODIUM, ALPRAZOLAM, |
||||
| 840 | 24982860 |
TR |
||
Blood glucose increased, Metastases to mouth, |
||||
ALPELISIB, |
||||
| 841 | 24982868 |
US |
||
Meniscus injury, Blood glucose increased, Glycosylated haemoglobin increased, Dysstasia, Vomiting, Hypersensitivity, Dyspnoea, |
||||
DAPAGLIFLOZIN, |
||||
| 842 | 24983030 |
US |
1 | |
Blood glucose increased, Glycosylated haemoglobin increased, Therapeutic product effect decreased, |
||||
EVOLOCUMAB, |
||||
| 843 | 24983127 |
US |
60 | 1 |
Injection site pain, Incorrect dose administered, Blood glucose increased, Drug ineffective, |
||||
DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, |
||||
| 844 | 24983161 |
US |
||
Muscle atrophy, Decreased appetite, Food intolerance, Urinary incontinence, Pain, Weight decreased, COVID-19, Vertigo, Cough, Exercise tolerance decreased, Bone loss, Blood glucose increased, Fatigue, Asthenia, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 845 | 24983254 |
US |
43 | 2 |
Foot fracture, Aversion, Hot flush, Blood glucose increased, |
||||
SEMAGLUTIDE, INSULIN ASPART, SECUKINUMAB, |
||||
| 846 | 24986278 |
62 | 2 | |
Alopecia, Blood glucose increased, |
||||
RISANKIZUMAB-RZAA, |
||||
| 847 | 24973738 |
JP |
2 | |
Diffuse large B-cell lymphoma refractory, Immune effector cell-associated neurotoxicity syndrome, CSF protein increased, Systemic mycosis, Neuropathy peripheral, Blood glucose increased, Cytomegalovirus test positive, |
||||
EPCORITAMAB-BYSP, EPCORITAMAB-BYSP, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE, CHLORPHENIRAMINE MALEATE, LEVOTHYROXINE, |
||||
| 848 | 24973739 |
US |
82 | 1 |
Fall, Shoulder fracture, Myocardial infarction, Blood glucose increased, Injection site haemorrhage, Arthralgia, Drug ineffective, Product quality issue, |
||||
EMPAGLIFLOZIN, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, |
||||
| 849 | 24974251 |
JP |
8 | 1 |
Malignant neoplasm progression, Blood glucose increased, Malaise, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, |
||||
| 850 | 24974406 |
US |
68 | 2 |
Incorrect dose administered, Headache, Dizziness, Muscle twitching, Osteoarthritis, Gastrooesophageal reflux disease, Blood glucose increased, Blood urea increased, Blood chloride increased, COVID-19, |
||||
ALECTINIB HYDROCHLORIDE, ALECTINIB HYDROCHLORIDE, RIVAROXABAN, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, ERGOCALCIFEROL, CALCIUM, ZOLPIDEM TARTRATE, |
||||
| 851 | 24974410 |
US |
68 | 1 |
Infection, Arthropathy, Blood glucose increased, |
||||
INSULIN ASPART, |
||||
| 852 | 24974456 |
US |
1 | |
Blood glucose increased, |
||||
FINASTERIDE, |
||||
| 853 | 24975082 |
US |
2 | |
Blood glucose increased, Hypertension, |
||||
TEPROTUMUMAB, |
||||
| 854 | 24975412 |
US |
48 | 2 |
Blood glucose increased, Glycosylated haemoglobin increased, Wrong technique in product usage process, Urticaria, |
||||
INSULIN GLARGINE, |
||||
| 855 | 24975720 |
CO |
62 | 2 |
Liver disorder, Transaminases increased, Blood glucose increased, |
||||
ORAL SEMAGLUTIDE, |
||||
| 856 | 24975728 |
CN |
53 | 1 |
Pancreatic disorder, Pancreatic neoplasm, Blood glucose increased, |
||||
HUMAN INSULIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 857 | 24975730 |
CO |
65 | 2 |
Visual impairment, Eye complication associated with device, Glaucoma, Intraocular lens implant, Blood glucose increased, |
||||
INSULIN DEGLUDEC, |
||||
| 858 | 24975800 |
US |
65 | 2 |
Blood glucose increased, Nasal congestion, Cough, Fatigue, Extra dose administered, Injection site coldness, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 859 | 24975967 |
US |
49 | 2 |
Incorrect dose administered, Blood glucose increased, Injection site injury, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 860 | 24976473 |
US |
67 | 1 |
Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 861 | 24976504 |
67 | ||
Musculoskeletal stiffness, Muscle atrophy, Limb discomfort, Dysarthria, Hypoacusis, Blood glucose increased, Hypersensitivity, Constipation, Taste disorder, |
||||
ESOMEPRAZOLE MAGNESIUM, MIRABEGRON, AMLODIPINE BESYLATE AND VALSARTAN, SENNOSIDES, |
||||
| 862 | 24976636 |
US |
52 | 2 |
Blood glucose increased, White blood cell count decreased, Red blood cell count decreased, Mean cell volume decreased, Mean cell haemoglobin decreased, Neutrophil count decreased, Lymphocyte count decreased, Carbohydrate antigen 15-3 increased, |
||||
PALBOCICLIB, |
||||
| 863 | 24976808 |
US |
47 | 1 |
Incorrect dose administered, Influenza, Blood glucose increased, Dyspepsia, Gastrooesophageal reflux disease, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 864 | 24977022 |
CA |
32 | 1 |
Adverse drug reaction, Anosognosia, Blood glucose increased, Blood prolactin abnormal, Condition aggravated, Disturbance in social behaviour, Insurance issue, Metabolic disorder, Personality change, Suicide attempt, Schizophrenia, Sedation, Dystonia, Sexual dysfunction, Dyskinesia, Drug ineffective, |
||||
ZIPRASIDONE, ARIPIPRAZOLE, ASENAPINE MALEATE, CLOZAPINE, PALIPERIDONE, PALIPERIDONE, PALIPERIDONE, PALIPERIDONE, LURASIDONE HYDROCHLORIDE, LURASIDONE HYDROCHLORIDE, LURASIDONE HYDROCHLORIDE, OLANZAPINE, PALIPERIDONE, PALIPERIDONE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, ZIPRASIDONE MESYLATE, OLANZAPINE, OLANZAPINE PAMOATE, |
||||
| 865 | 24977280 |
US |
54 | 1 |
Incorrect dose administered, Blood glucose increased, Visual impairment, Injection site discomfort, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 866 | 24977888 |
US |
83 | 1 |
Thrombocytopenia, Pancytopenia, Anaemia, Blood glucose increased, |
||||
TALAZOPARIB, TALAZOPARIB, TALAZOPARIB, ENZALUTAMIDE, ENZALUTAMIDE, LEUPROLIDE ACETATE, |
||||
| 867 | 24978015 |
US |
66 | 2 |
Blood glucose increased, |
||||
NICOTINE POLACRILEX, NICOITNE POLACRILEX, NICOTINE POLACRILEX GUM, NICOTINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MELOXICAM, |
||||
| 868 | 24978023 |
US |
||
Blood glucose increased, |
||||
NICOTINE POLACRILEX, NICOITNE POLACRILEX, NICOTINE POLACRILEX GUM, NICOTINE, |
||||
| 869 | 24978039 |
US |
67 | 1 |
Blood glucose increased, |
||||
NICOTINE POLACRILEX, NICOITNE POLACRILEX, NICOTINE POLACRILEX GUM, NICOTINE, DULAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LISINOPRIL, AMLODIPINE, |
||||
| 870 | 24978076 |
US |
63 | 2 |
Gait disturbance, Blood glucose increased, Incorrect product administration duration, Product storage error, Abdominal pain upper, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 871 | 24978447 |
US |
37 | 1 |
Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 872 | 24981637 |
46 | 2 | |
Insomnia, Headache, Oropharyngeal pain, Rhinorrhoea, Photosensitivity reaction, Blood pressure increased, Blood glucose increased, |
||||
EVOLOCUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, VITAMIN A, VITAMIN C, ERGOCALCIFEROL, VITAMIN E, CREAM, PHYTONADIONE, FOLIC ACID, GARLIC, LUTEIN, OIL, BIOTIN, HAIR, PRASTERONE, MAGNESIUM GLYCINATE, IRON, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 873 | 24981780 |
56 | 1 | |
Hypertension, Blood glucose increased, Hypoxia, Myalgia, Headache, Fatigue, Asthenia, |
||||
BELZUTIFAN, |
||||
| 874 | 24973136 |
US |
58 | 1 |
Incorrect dose administered, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 875 | 24973146 |
US |
53 | 2 |
Thinking abnormal, Memory impairment, Feeling abnormal, Blood glucose increased, Product dose omission issue, Incorrect product administration duration, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 876 | 24973174 |
US |
79 | 1 |
Cataract, Hypoacusis, Visual impairment, Blood glucose decreased, Therapeutic product effect delayed, Therapeutic product effect decreased, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 877 | 24973192 |
US |
6 | 2 |
Blood glucose increased, Inflammation, Injection site reaction, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 878 | 24973250 |
US |
58 | 2 |
Sinusitis, Cold sweat, Blood glucose increased, Discomfort, Chest discomfort, Dizziness, Glycosylated haemoglobin increased, Flatulence, |
||||
DULAGLUTIDE, DULAGLUTIDE, EMPAGLIFLOZIN, |
||||
| 879 | 24973254 |
US |
75 | 1 |
Blood glucose increased, Wrong technique in product usage process, |
||||
INSULIN LISPRO, |
||||
| 880 | 24973276 |
US |
42 | 2 |
Pulmonary thrombosis, Blood glucose increased, Thrombosis, |
||||
ADALIMUMAB, |
||||
| 881 | 24973547 |
US |
1 | |
Myocardial infarction, Coronary artery occlusion, Blood glucose increased, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, |
||||
| 882 | 24972359 |
51 | ||
Bell^s palsy, Abdominal discomfort, Hypoaesthesia, Gastrointestinal disorder, Anxiety, Pain, Stress, Blood glucose increased, Product use in unapproved indication, Off label use, Product dose omission issue, |
||||
ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, LISINOPRIL, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, INSULIN GLARGINE, GABAPENTIN, |
||||
| 883 | 24972535 |
US |
77 | 2 |
Glycosylated haemoglobin increased, Hypersensitivity, Drug ineffective, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 884 | 24972563 |
US |
72 | 2 |
Glycosylated haemoglobin increased, Visual impairment, Drug ineffective, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 885 | 24972564 |
US |
1 | |
Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 886 | 24972596 |
US |
1 | |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 887 | 24972677 |
US |
77 | 1 |
Back pain, Blood glucose increased, Muscular weakness, Device malfunction, |
||||
TREPROSTINIL, TREPROSTINIL, PREDNISONE, EMPAGLIFLOZIN, AMOXICILLIN, ALBUTEROL SULFATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, PANCRELIPASE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OXYGEN, 0XYGEN, FUROSEMIDE, ERGOCALCIFEROL, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, INSULIN GLARGINE-YFGN, SITAGLIPTIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 888 | 24972715 |
US |
61 | 2 |
Glycosylated haemoglobin increased, Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, |
||||
| 889 | 24972894 |
US |
78 | 1 |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 890 | 24967609 |
US |
2 | |
Blood glucose increased, |
||||
OMALIZUMAB, |
||||
| 891 | 24967847 |
MX |
5 | 2 |
Pneumonia, Infection, Blood glucose increased, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 892 | 24968206 |
US |
58 | 2 |
Blood glucose increased, Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 893 | 24968265 |
JP |
||
Glycosylated haemoglobin increased, Blood glucose increased, Diarrhoea, |
||||
BRIGATINIB, |
||||
| 894 | 24968588 |
US |
79 | 1 |
Osteoarthritis, Arthralgia, Blood glucose increased, Knee arthroplasty, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, FINASTERIDE, CHLORTHALIDONE, AMLODIPINE, |
||||
| 895 | 24968603 |
US |
82 | 1 |
Urinary retention, Blood glucose increased, |
||||
| 896 | 24968822 |
CA |
50 | 2 |
Angioedema, Bite, Blood cholesterol increased, Blood glucose increased, Bronchitis, Eye pruritus, Eye swelling, Food poisoning, Genital rash, Hypersensitivity, Hypertension, Ocular hyperaemia, Paraesthesia, Pruritus, Rash, Sinusitis, Urticaria, Drug ineffective, Therapy partial responder, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, BEPOTASTINE BESILATE, BEPOTASTINE BESILATE, BEPOTASTINE BESILATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, DRONABINOL, FLUTICASONE PROPIONATE, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PREDNISONE, PREDNISONE, PREDNISONE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, |
||||
| 897 | 24968864 |
US |
71 | 1 |
Blood glucose increased, Product dose omission issue, Injection site haemorrhage, Injection site pain, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 898 | 24969053 |
US |
70 | 2 |
Blood glucose increased, |
||||
| 899 | 24969140 |
US |
75 | 2 |
Neoplasm malignant, Blood creatine increased, Blood urea increased, Blood glucose increased, Decreased appetite, |
||||
EMPAGLIFLOZIN, |
||||
| 900 | 24969298 |
CN |
64 | 1 |
Drug ineffective, Impaired quality of life, Product use in unapproved indication, Blood glucose increased, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PYRIDOSTIGMINE BROMIDE ORAL, PYRIDOSTIGMINE BROMIDE ORAL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28